The metabolic signaling of the nucleoredoxin-like 2 gene supports brain function

The nucleoredoxin gene NXNL2 encodes for two products through alternative splicing, rod-derived cone viability factor-2 (RdCVF2) that mediates neuronal survival and the thioredoxin-related protein (RdCVF2L), an enzyme that regulates the phosphorylation of TAU. To investigate the link between NXNL2 a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Céline Jaillard, Farah Ouechtati, Emmanuelle Clérin, Géraldine Millet-Puel, Mariangela Corsi, Najate Aït-Ali, Frédéric Blond, Quentin Chevy, Lara Gales, Mélissa Farinelli, Deniz Dalkara, José-Alain Sahel, Jean-Charles Portais, Jean-Christophe Poncer, Thierry Léveillard
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/ad3fc9da614f44d681064fa163f7b7dd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ad3fc9da614f44d681064fa163f7b7dd
record_format dspace
spelling oai:doaj.org-article:ad3fc9da614f44d681064fa163f7b7dd2021-12-02T05:01:31ZThe metabolic signaling of the nucleoredoxin-like 2 gene supports brain function2213-231710.1016/j.redox.2021.102198https://doaj.org/article/ad3fc9da614f44d681064fa163f7b7dd2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S221323172100358Xhttps://doaj.org/toc/2213-2317The nucleoredoxin gene NXNL2 encodes for two products through alternative splicing, rod-derived cone viability factor-2 (RdCVF2) that mediates neuronal survival and the thioredoxin-related protein (RdCVF2L), an enzyme that regulates the phosphorylation of TAU. To investigate the link between NXNL2 and tauopathies, we studied the Nxnl2 knockout mouse (Nxnl2−/−). We established the expression pattern of the Nxnl2 gene in the brain using a Nxnl2 reporter mouse line, and characterized the behavior of the Nxnl2−/− mouse at 2 months of age. Additionally, long term potential recording and metabolomic from hippocampal specimens were collected at 2 months of age. We studied TAU oligomerization, phosphorylation and aggregation in Nxnl2−/− brain at 18 months of age. Finally, newborn Nxnl2−/− mice were treated with adeno-associated viral vectors encoding for RdCVF2, RdCVF2L or both and measured the effect of this therapy on long-term potential, glucose metabolism and late-onset tauopathy. Nxnl2−/− mice at 2 months of age showed severe behavioral deficiency in fear, pain sensitivity, coordination, learning and memory. The Nxnl2−/− also showed deficits in long-term potentiation, demonstrating that the Nxnl2 gene is involved in regulating brain functions. Dual delivery of RdCVF2 and RdCVF2L in newborn Nxnl2−/− mice fully correct long-term potentiation through their synergistic action. The expression pattern of the Nxnl2 gene in the brain shows a predominant expression in circumventricular organs, such as the area postrema. Glucose metabolism of the hippocampus of Nxnl2−/− mice at 2 months of age was reduced, and was not corrected by gene therapy. At 18-month-old Nxnl2−/− mice showed brain stigmas of tauopathy, such as oligomerization, phosphorylation and aggregation of TAU. This late-onset tauopathy can be prevented, albeit with modest efficacy, by recombinant AAVs administrated to newborn mice. The Nxnl2−/− mice have memory dysfunction at 2-months that resembles mild-cognitive impairment and at 18-months exhibit tauopathy, resembling to the progression of Alzheimer's disease. We propose the Nxnl2−/− mouse is a model to study multistage aged related neurodegenerative diseases. The NXNL2 metabolic and redox signaling is a new area of therapeutic research in neurodegenerative diseases.Céline JaillardFarah OuechtatiEmmanuelle ClérinGéraldine Millet-PuelMariangela CorsiNajate Aït-AliFrédéric BlondQuentin ChevyLara GalesMélissa FarinelliDeniz DalkaraJosé-Alain SahelJean-Charles PortaisJean-Christophe PoncerThierry LéveillardElsevierarticleGlucose metabolismThioredoxinTauopathyLong-term potentiationMetabolomicsHippocampusMedicine (General)R5-920Biology (General)QH301-705.5ENRedox Biology, Vol 48, Iss , Pp 102198- (2021)
institution DOAJ
collection DOAJ
language EN
topic Glucose metabolism
Thioredoxin
Tauopathy
Long-term potentiation
Metabolomics
Hippocampus
Medicine (General)
R5-920
Biology (General)
QH301-705.5
spellingShingle Glucose metabolism
Thioredoxin
Tauopathy
Long-term potentiation
Metabolomics
Hippocampus
Medicine (General)
R5-920
Biology (General)
QH301-705.5
Céline Jaillard
Farah Ouechtati
Emmanuelle Clérin
Géraldine Millet-Puel
Mariangela Corsi
Najate Aït-Ali
Frédéric Blond
Quentin Chevy
Lara Gales
Mélissa Farinelli
Deniz Dalkara
José-Alain Sahel
Jean-Charles Portais
Jean-Christophe Poncer
Thierry Léveillard
The metabolic signaling of the nucleoredoxin-like 2 gene supports brain function
description The nucleoredoxin gene NXNL2 encodes for two products through alternative splicing, rod-derived cone viability factor-2 (RdCVF2) that mediates neuronal survival and the thioredoxin-related protein (RdCVF2L), an enzyme that regulates the phosphorylation of TAU. To investigate the link between NXNL2 and tauopathies, we studied the Nxnl2 knockout mouse (Nxnl2−/−). We established the expression pattern of the Nxnl2 gene in the brain using a Nxnl2 reporter mouse line, and characterized the behavior of the Nxnl2−/− mouse at 2 months of age. Additionally, long term potential recording and metabolomic from hippocampal specimens were collected at 2 months of age. We studied TAU oligomerization, phosphorylation and aggregation in Nxnl2−/− brain at 18 months of age. Finally, newborn Nxnl2−/− mice were treated with adeno-associated viral vectors encoding for RdCVF2, RdCVF2L or both and measured the effect of this therapy on long-term potential, glucose metabolism and late-onset tauopathy. Nxnl2−/− mice at 2 months of age showed severe behavioral deficiency in fear, pain sensitivity, coordination, learning and memory. The Nxnl2−/− also showed deficits in long-term potentiation, demonstrating that the Nxnl2 gene is involved in regulating brain functions. Dual delivery of RdCVF2 and RdCVF2L in newborn Nxnl2−/− mice fully correct long-term potentiation through their synergistic action. The expression pattern of the Nxnl2 gene in the brain shows a predominant expression in circumventricular organs, such as the area postrema. Glucose metabolism of the hippocampus of Nxnl2−/− mice at 2 months of age was reduced, and was not corrected by gene therapy. At 18-month-old Nxnl2−/− mice showed brain stigmas of tauopathy, such as oligomerization, phosphorylation and aggregation of TAU. This late-onset tauopathy can be prevented, albeit with modest efficacy, by recombinant AAVs administrated to newborn mice. The Nxnl2−/− mice have memory dysfunction at 2-months that resembles mild-cognitive impairment and at 18-months exhibit tauopathy, resembling to the progression of Alzheimer's disease. We propose the Nxnl2−/− mouse is a model to study multistage aged related neurodegenerative diseases. The NXNL2 metabolic and redox signaling is a new area of therapeutic research in neurodegenerative diseases.
format article
author Céline Jaillard
Farah Ouechtati
Emmanuelle Clérin
Géraldine Millet-Puel
Mariangela Corsi
Najate Aït-Ali
Frédéric Blond
Quentin Chevy
Lara Gales
Mélissa Farinelli
Deniz Dalkara
José-Alain Sahel
Jean-Charles Portais
Jean-Christophe Poncer
Thierry Léveillard
author_facet Céline Jaillard
Farah Ouechtati
Emmanuelle Clérin
Géraldine Millet-Puel
Mariangela Corsi
Najate Aït-Ali
Frédéric Blond
Quentin Chevy
Lara Gales
Mélissa Farinelli
Deniz Dalkara
José-Alain Sahel
Jean-Charles Portais
Jean-Christophe Poncer
Thierry Léveillard
author_sort Céline Jaillard
title The metabolic signaling of the nucleoredoxin-like 2 gene supports brain function
title_short The metabolic signaling of the nucleoredoxin-like 2 gene supports brain function
title_full The metabolic signaling of the nucleoredoxin-like 2 gene supports brain function
title_fullStr The metabolic signaling of the nucleoredoxin-like 2 gene supports brain function
title_full_unstemmed The metabolic signaling of the nucleoredoxin-like 2 gene supports brain function
title_sort metabolic signaling of the nucleoredoxin-like 2 gene supports brain function
publisher Elsevier
publishDate 2021
url https://doaj.org/article/ad3fc9da614f44d681064fa163f7b7dd
work_keys_str_mv AT celinejaillard themetabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT farahouechtati themetabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT emmanuelleclerin themetabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT geraldinemilletpuel themetabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT mariangelacorsi themetabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT najateaitali themetabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT fredericblond themetabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT quentinchevy themetabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT laragales themetabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT melissafarinelli themetabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT denizdalkara themetabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT josealainsahel themetabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT jeancharlesportais themetabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT jeanchristopheponcer themetabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT thierryleveillard themetabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT celinejaillard metabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT farahouechtati metabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT emmanuelleclerin metabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT geraldinemilletpuel metabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT mariangelacorsi metabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT najateaitali metabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT fredericblond metabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT quentinchevy metabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT laragales metabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT melissafarinelli metabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT denizdalkara metabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT josealainsahel metabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT jeancharlesportais metabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT jeanchristopheponcer metabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
AT thierryleveillard metabolicsignalingofthenucleoredoxinlike2genesupportsbrainfunction
_version_ 1718400785682792448